Conmed (CNMD) Amortization of Deferred Charges (2019 - 2026)

Conmed (CNMD) has 8 years of Amortization of Deferred Charges data on file, last reported at $1.1 million in Q2 2026.

• Quarterly Amortization of Deferred Charges fell 24.06% year-over-year to $1.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.1 million (down 10.02% YoY) and the FY2025 annual result came in at $5.6 million, down 0.95% from the prior year.
• Amortization of Deferred Charges declined to $1.1 million in Q2 2026, from $1.3 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $1.5 million in Q3 2023 to a low of $880000.0 in Q1 2022.
• A 5-year average of $1.4 million and a median of $1.4 million in 2024 frame the typical range for Amortization of Deferred Charges.
• Annual changes were most pronounced in 2022 — Amortization of Deferred Charges jumped 93.08% — and 2026, when it dropped 24.06%.
• Tracing CNMD's Amortization of Deferred Charges over 5 years: stood at $1.5 million in 2022, then declined by 0.4% to $1.5 million in 2023, then dropped by 3.73% to $1.4 million in 2024, then rose by 6.58% to $1.5 million in 2025, then slumped by 31.51% to $1.1 million in 2026.
• The last three Amortization of Deferred Charges figures came in at $1.1 million (Q2 2026), $1.3 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.